Company profile
Engitix Therapeutics
Decoding the ECM space to unlock unprecedented therapies for chronic diseases
- Industry
- Biotechnology Research
- Employees
- 61
- Headquarters
- London, England
- Founded
- 2016
- LinkedIn followers
- 9,047
- Office locations
- 3
Engitix Therapeutics company summary
Engitix Therapeutics is a company in the Biotechnology Research industry, headquartered in London, England, founded in 2016. On LinkedIn the company has around 61 employees and 9,047 followers. The company lists 3 office locations. Its listed specialties include Tissue engineering, Drug Discovery, Extracellular matrix, Liver Fibrosis, Pancreatic cancer.
What technology does Engitix Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Engitix Therapeutics
To create a healthier future for patients with life-threatening diseases, we are using our pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumours. Using human in vitro models that better recreate the natural cell microenvironment is transforming our ability to identify new targets, determine mechanisms of action, and increase the success rate of therapeutic candidates. We have pioneered the world’s first human extracellular matrix-based discovery platform to aid in the discovery of targets and biomarkers as well as drug profiling. Using our technology, we have a unique ability to study tissue- and disease-specific human ECM scaffolds, and to model diseases to study mechanisms of action. Our improved understanding of the role of the ECM in human enables the identification of more relevant drug targets and biomarkers. For drug discovery, we incorporate human ECM into our in vitro models, thereby recreating the natural cell microenvironment so that drug candidates can be tested in the context they will ultimately be used in. With the potential to predict the efficacy of candidates more accurately at an earlier stage, the platform can reduce late-stage clinical failures and accelerate discovery.
Specialties
Where is Engitix Therapeutics located?
Engitix Therapeutics lists 3 office locations.
Compare companies similar to Engitix Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Engitix Therapeutics engitix.com | Biotechnology Research | 61 | 2016 | London, England |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Engitix Therapeutics
What does Engitix Therapeutics do?
To create a healthier future for patients with life-threatening diseases, we are using our pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumours. Using human in vitro models that better recreate the natural cell microenvironment is transforming our ability to identify new targets, determine mechanisms of action, and increase the success rate of therapeutic candidates. We have pioneered the world’s first human extracellular matrix-based discovery platform to aid in the discovery of targets and biomarkers as well as drug profiling. Using our technology, we have a unique ability to study tissue- and disease-specific human ECM scaffolds, and to model diseases to study mechanisms of action. Our improved understanding of the role of the ECM in human enables the identification of more relevant drug targets and biomarkers. For drug discovery, we incorporate human ECM into our in vitro models, thereby recreating the natural cell microenvironment so that drug candidates can be tested in the context they will ultimately be used in. With the potential to predict the efficacy of candidates more accurately at an earlier stage, the platform can reduce late-stage clinical failures and accelerate discovery.
How many employees does Engitix Therapeutics have?
Engitix Therapeutics has around 61 employees on LinkedIn.
Where is Engitix Therapeutics headquartered?
Engitix Therapeutics is headquartered in London, England.
Where does Engitix Therapeutics have offices?
Engitix Therapeutics lists 3 office locations, including London, England EC3V 9AH, GB; Cambridge, Massachusetts, US; London, London NW32PF, GB.
When was Engitix Therapeutics founded?
Engitix Therapeutics was founded in 2016.
Build a lead list from companies like Engitix Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.